{
    "clinical_study": {
        "@rank": "60659", 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the safety and effectiveness of a high dose of\n      ABT-378/ritonavir"
        }, 
        "brief_title": "A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors", 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion:\n\n          -  HIV positive\n\n          -  Are at least 18 years old\n\n          -  Subject has not been treated for an active AIDS-defining opportunistic infection\n             within 15 days of screening\n\n          -  HIV RNA level > 1000 copies/mL\n\n          -  Previous therapy with at least one protease inhibitor, at least one non-nucleoside\n             reverse transcriptase inhibitor and at least one nucleoside reverse transcriptase\n             inhibitor\n\n        Exclusion:\n\n          -  Subject is pregnant or breast-feeding\n\n          -  Subject has received an investigational drug within 30 days prior to screening\n\n          -  Have a history of pancreatitis\n\n          -  History of intolerance to ritonavir\n\n          -  Abnormal laboratory tests at screening"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "36", 
        "firstreceived_date": "June 3, 2002", 
        "id_info": {
            "nct_alias": "NCT00006210", 
            "nct_id": "NCT00038636", 
            "org_study_id": "M99-049"
        }, 
        "intervention": [
            {
                "intervention_name": "Lopinavir/ritonavir", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Ritonavir", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Protease Inhibitors", 
                "Ritonavir", 
                "Lopinavir", 
                "HIV Protease Inhibitors", 
                "Reverse Transcriptase Inhibitors"
            ]
        }, 
        "keyword": "HIV", 
        "lastchanged_date": "August 13, 2006", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92103-6329"
                    }, 
                    "name": "UCSD Treatment Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21287"
                    }, 
                    "name": "Johns Hopkins Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chapel Hill", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27599"
                    }, 
                    "name": "The University of North Carolina at Chapel Hill"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75651"
                    }, 
                    "name": "Hopital Pitie-Salpetriere"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75908"
                    }, 
                    "name": "Hospital Europeen Georges Pompidou"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08036"
                    }, 
                    "name": "Hospital Clinico de Barcelona"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08907"
                    }, 
                    "name": "Ciutat Sanitaria de Bellvitge"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "France", 
                "Spain"
            ]
        }, 
        "official_title": "A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors", 
        "overall_official": {
            "affiliation": "Divisional Vice President, Infectious Diseases and Virology Dept.", 
            "last_name": "Eugene Sun, M.D.", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "primary_outcome": {
            "measure": "Virologic and immunologic activity evaluations include plasma HIV RNA, CD4 and CD8 cell counts"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00038636"
        }, 
        "source": "Abbott", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Abbott", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2000", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2006"
    }, 
    "geocoordinates": {
        "Ciutat Sanitaria de Bellvitge": "41.388 2.17", 
        "Hopital Pitie-Salpetriere": "48.857 2.352", 
        "Hospital Clinico de Barcelona": "41.388 2.17", 
        "Hospital Europeen Georges Pompidou": "48.857 2.352", 
        "Johns Hopkins Hospital": "39.29 -76.612", 
        "The University of North Carolina at Chapel Hill": "35.913 -79.056", 
        "UCSD Treatment Center": "32.715 -117.157"
    }
}